Professional Documents
Culture Documents
Bjan-Safety Venilation in Ect During Covid
Bjan-Safety Venilation in Ect During Covid
5with severe psychomotor agitation, and status epilepticus (1). Although this is a life-
6saving treatment, maintaining the functioning of ECT services during the COVID-19
7pandemic has become a challenge due to the intrinsic risks of the anesthetic and
8ventilatory approach during the procedure (2). Anesthesia for performing ECT consists
10neuromuscular blocker, the most used being succinylcholine due to its rapid onset and
11offset of action. Oxygen support is provided through non-invasive ventilation via bag
12and mask (3). This is a critical point in the procedure because non-invasive ventilation
14ventilated patients. To address this challenge, some services are using a laryngeal mask
15(LMA) for ventilation, others are trying not to ventilate patients during the procedure,
16using preoxygenation via a non-rebreather mask. The latter can be dangerous because
17the patient’s oxygen saturation may drop to a level that requires ventilatory support
18during the procedure. Although the procedure is fast enough to allow the use of LMA,
19the risk of contamination due to the aerosol spray does not decrease significantly; in
22installing a HEPA (high-efficiency particulate arrestance) filter between the bag and the
23mask to retain the viral particles. In addition, a sterile plastic bag surrounding the mask
24and the patient’s face was attached to the ventilation system. This device protects
25against the aerosol that may escape from between the mouth and the mask and
26spread viral particles around the ECT room. The edge of the plastic bag can be fixed
27with clamps. All ventilation material is replaced between patients. The use of low O 2
29anesthesiologist, and nurse should all use personal protective equipment such as an
30N95 mask and a face shield, gloves, and an impermeable gown. We believe this is a
31safe and effective way to reduce the risk of contamination during the ECT procedure.
32
33REFERENCES
341. Espinoza RT, Kellner CH, McCall WV. Electroconvulsive Therapy During COVID-19: An
36 2020;36(2):78-79. doi:10.1097/YCT.0000000000000689.
372. Tor, Phern Chern;Phu, Adeline H;Koh, Doris S H;Mok, Yee Ming. ECT in a time of COVID-
41 treatment, training, and privileges: a task force report of the American Psychiatric
434. Bryson EO, Aloysi AS. A strategy for management of ECT patients during the COVID-19
44 pandemic [published online ahead of print, 2020 May 12]. J ECT. 2020;
45 doi:10.1097/YCT.000000000702